Bayard D. Clarkson

Last updated

Bayard Delafield Clarkson Sr. (born July 15, 1926) is an American physician, hematologist, and oncologist.

Contents

Biography

Clarkson was born in New York City on July 15, 1926. He is the son of the wealthy banker, Robert Livingston Clarkson Sr. (1892–1969), who was the president of Chase National Bank from 1928 to 1929. R. L. Clarkson Sr. and his wife Cora G. Clarkson née Shields (1897–1981) had two other sons, Robert Livingston Clarkson Jr. (1924–1965) and Peter Schuyler Clarkson (1930–1950). The Clarkson family is related to Matthew Clarkson (1758–1825) and is connected to Clark University. [1] [2] When the attack on Pearl Harbor occurred, Bayard Clarkson was attending New Hampshire's St. Paul's School. In December 1943 he enlisted in the U.S. Navy's aviation program. However, he was diagnosed with inactive tuberculosis and judged ineligible for active duty. Thereupon, he joined the American Field Service (AFS). In the summer of 1944, AFS sent him orders for two weeks of basic training, after which he was sent overseas in August 1944. From early September 1944 through March 1945 he served in Italy with Unit CM 90 of the AFS. In the spring of 1945 he volunteered for service in the evacuation of Bergen-Belsen concentration camp. In July 1945, he shipped out from Copenhagen. In autumn 1945 he matriculated at Yale University. [1]

After graduating from Yale, Clarkson studied medicine at the Columbia University College of Physicians and Surgeons, where he graduated with an M.D. in 1952. At New York Hospital (now called Weill Cornell Medical Center), he served his medical internship and residency [3] in endocrinology and hematology. [4] In 1958 he became a Special Lasker Fellow in Clinical Chemotherapy at (what became in 1960) the Memorial Sloan Kettering Cancer Center (MSKCC), where he continued working and coauthoring articles [5] until 2017. [6] AT MSKCC he became in 1970 the Chief of the Hematology Service and in 1980 the Enid A. Haupt Chair of Therapeutic Research. He was from 1975 to 1989 the MSKCC's Chief of the Hematology/Lymphoma Service. [5]

At the beginning of his career of MSKCC he worked with three outstanding chemotherapy pioneers, David Karnofsky, Cornelius Rhoads, and Joseph Burchenal. Clarkson and his colleagues were among the first to develop effective therapies for adults with acute leukemias and lymphomas. [3] [7] Much of his work focused on the search for selectively targetable differences between normal cells and abnormal stem cells that are quiescent (but potentially proliferative) in CML (Chronic Myelogenous Leukemia). [8] He is a leading expert on the "intracellular signaling pathways that are altered by the BCR/ABL fusion genes". [3]

From 1968 to 1992, Clarkson was a trustee of Cold Spring Harbor Laboratory. [5] From 1973 to 1974 he was the president of the American Society of Clinical Oncology (ASCO). [3] From 1980 to 1981 he was the president of the American Association for Cancer Research (AACR). [5]

In 1946 in Keene, New Hampshire he married Virginia Lomax Clark (1926–2019). They had three daughters and one son. [9] [10]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Acute lymphoblastic leukemia</span> Blood cancer characterised by overproduction of lymphoblasts

Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. Symptoms may include feeling tired, pale skin color, fever, easy bleeding or bruising, enlarged lymph nodes, or bone pain. As an acute leukemia, ALL progresses rapidly and is typically fatal within weeks or months if left untreated.

<span class="mw-page-title-main">John Edgar Dick</span> Canadian cancer researcher (born 1954)

John Edgar Dick is Canada Research Chair in Stem Cell Biology, Senior Scientist at the Princess Margaret Cancer Centre, University Health Network and Professor in the Department of Molecular Genetics at the University of Toronto in Canada. Dick is credited with first identifying cancer stem cells in certain types of human leukemia. His revolutionary findings highlighted the importance of understanding that not all cancer cells are the same and thus spawned a new direction in cancer research. Dick is also known for his demonstration of a blood stem cell's ability to replenish the blood system of a mouse, his development of a technique to enable an immune-deficient mouse to carry and produce human blood, and his creation of the world's first mouse with human leukemia.

<span class="mw-page-title-main">Charles Sawyers</span> American physician-scientist (born 1959)

Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.

<span class="mw-page-title-main">Brian Druker</span> American physician-scientist

Brian J. Druker, M.D. is a physician-scientist at Oregon Health & Science University (OHSU), in Portland, Oregon. He is the chief executive officer of OHSU's Knight Cancer Institute, JELD-WEN Chair of Leukemia Research, Associate Dean for Oncology in the OHSU School of Medicine, and professor of medicine.

Clara Derber Bloomfield, was an American physician and cancer researcher. Her work focused on the genetic changes that are present in certain types of blood cancers, and how those can be utilized to improve treatment for the affected patients.

Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility. He is currently the director of the Center for DNA Damage and Repair and the director of the Susan F. Smith Center for Women's Cancer.

Peter K. Vogt is an American molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.

<span class="mw-page-title-main">Roland Mertelsmann</span>

Roland Mertelsmann is a German hematologist and oncologist. He was a professor at the Freiburg University Medical Center, Department of Internal Medicine I (Oncology/Hematology). Mertelsmann is known for his scientific works in the fields of hematology, oncology, gene therapy and stem cell transplantation.

Owen Witte is an American physician-scientist at the University of California, Los Angeles. He is a University Professor of microbiology, immunology and molecular genetics in the David Geffen School of Medicine at UCLA, founding director emeritus of the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, and the UC Regents’ David Saxon Presidential Chair in developmental immunology (1989–present). Witte is also a Howard Hughes Medical Institute investigator (1986–2016) and a member of the President's Cancer Panel, the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the Cancer Research Academy of the AACR. He serves on numerous editorial boards and scientific advisory boards for academic centers and biotechnology companies.

<span class="mw-page-title-main">Carl H. June</span> American immunologist and oncologist

Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.

Joseph Rocco Bertino was an American researcher in the cancer pharmacology program at Rutgers Cancer Institute of New Jersey and professor of medicine and pharmacology at the Robert Wood Johnson Medical School in New Jersey. His research focused on the treatment of lymphoma.

<span class="mw-page-title-main">Crystal Mackall</span> American physician and immunologist

Crystal L. Mackall is an American physician and immunologist. She is currently the Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine at Stanford University. She is the founding director of the Stanford Center for Cancer Cell Therapy.

Marcela V. Maus is a professor of medicine at Harvard Medical School and director of the Cellular Immunotherapy Program at Massachusetts General Hospital. She works on immunotherapy for the treatment of cancer, using genetically engineered T cells to target malignancies (cancer).

<span class="mw-page-title-main">Carcinocythemia</span> Tumour cells on blood smear

Carcinocythemia, also known as carcinoma cell leukemia, is a condition in which cells from malignant tumours of non-hematopoietic origin are visible on the peripheral blood smear. It is an extremely rare condition, with 33 cases identified in the literature from 1960 to 2018. Carcinocythemia typically occurs secondary to infiltration of the bone marrow by metastatic cancer and carries a very poor prognosis.

Roy S. Herbst is an American oncologist who is the Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center and Yale School of Medicine in New Haven, Connecticut.

<span class="mw-page-title-main">June Biedler</span> American scientist

June Biedler was an American scientist primarily known for her discovery of proteins that lead to resistance of cancer cells to chemotherapy. Her work has been crucial for an understanding of both the development of drug resistance and also for strategies to circumvent such resistance. In addition, Biedler made important contributions to an understanding of the molecular mechanisms of neuroblastoma development, particularly of the role of the N-myc oncogene in the genesis of neuroblastoma

Scott Allen Armstrong is an American pediatric oncologist and cancer biologist focused on chromatin-based control of gene expression in cancer and therapeutic discovery. Armstrong and his team were the first to isolate rare leukemia stem cells in a mouse model of leukemia.

<span class="mw-page-title-main">Chi Van Dang</span> Hematological oncologist

Chi Van Dang is a hematological oncologist and researcher, currently serving as the Scientific Director of Ludwig Institute for Cancer Research. He is known for his research on genetics, the MYC gene and the cellular energy metabolism of cancer.

Philip Greenberg is a professor of medicine, oncology, and immunology at the University of Washington and head of program in immunology at the Fred Hutchinson Cancer Research Center. His research is centered around T cell biology and therapeutic cell therapies. He is a co-founder of Juno Therapeutics.

The LL-100 panel is a group of 100 human leukemia and lymphoma cell line, can be used in model of biomedical research.

References

  1. 1 2 "Bayard D. Clarkson: Taking on the Challenges of the Unknown". AFS Janus, a publication of the Archives of the American Field Service, AFS Virtual Museum Library - Issuu. Spring 2014.
  2. ↑ "Board of Trustees | Clarkson University".
  3. 1 2 3 4 "Bayard Clarkson, MD". Memorial Sloan Kettering Cancer Center. (with link to Bayard Clarkson's journal articles)
  4. ↑ Milano, Carol. "First Leader. Bayard D. Clarkson, MD".
  5. 1 2 3 4 "Bayard D. Clarkson, MD". American Academy for Cancer Research (AACR).
  6. ↑ Patel, Sapan J.; Trivedi, Gaurang L.; Darie, Costel C.; Clarkson, Bayard D. (2017). "The possible roles of B-cell novel protein-1 (BCNP1) in cellular signalling pathways and in cancer". Journal of Cellular and Molecular Medicine. 21 (3): 456–466. doi:10.1111/jcmm.12989. PMC   5323820 . PMID   27680505.
  7. ↑ "Bayard D. Clarkson, MD". Our Leadership, American Association for Cancer Research.
  8. ↑ "Bayard Clarkson". NYSTEM, New York State Stem Cell Science, Department of Health, Wadsworth Center.
  9. ↑ "Clarkson University Mourns the Passing of Clarkson Family Member Virginia "Ginny" Clark Clarkson Hon. '89". News, Clarkson University. December 23, 2019.
  10. ↑ "Obituary of Virginia Clarkson | Dodge-Thomas Inc Funeral Home".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.